about
Nucleic acid aptamers: research tools in disease diagnostics and therapeuticsWaveguide-mode sensors as aptasensorsSelection of RNA aptamers that are specific and high-affinity ligands of the hepatitis C virus RNA-dependent RNA polymeraseMolecular Mechanism for Inhibition of G Protein-Coupled Receptor Kinase 2 by a Selective RNA AptamerScreening of peptide ligands for pyrroloquinoline quinone glucose dehydrogenase using antagonistic template-based biopanningLocal neutral networks help maintain inaccurately replicating ribozymesNucleic acid aptamers as tools and drugs: recent developments.The Proteomic Code: a molecular recognition code for proteins.RNA as a versatile and powerful platform for engineering genetic regulatory tools.Advances and perspectives in aptamer arrays.Characterisation of aptamers for therapeutic studies.A novel strategy for selection of allosteric ribozymes yields RiboReporter sensors for caffeine and aspartame.In-gel imaging of RNA processing using broccoli reveals optimal aptamer expression strategies.An RNA molecule that specifically inhibits G-protein-coupled receptor kinase 2 in vitro.Selective aptamer-based control of intraneuronal signalingNucleic acid aptamers for target validation and therapeutic applications.Biomolecular discrimination analyses by surface plasmon resonance.JNK, p38, ERK, and SGK1 Inhibitors in Cancer.Sec, drugs and rock’n’roll: antibiotic targeting of bacterial protein translocation
P2860
Q26824321-87BE537F-B743-47FB-A2F7-3B8043E60612Q26996166-B0C18347-6D03-45F4-995C-2D809581C55BQ27472862-7FA07F2B-8DA1-45B4-B68D-79C1F9361789Q27681349-F87A32BF-4934-4AE0-AFB5-CB6111CA18EBQ35056244-F9D58F2B-412D-45AB-A1DA-C218550BA583Q35316425-89BE0B22-B49A-4D3C-80B0-FD98CC1F7E6EQ35549348-C31FAE8B-4A06-44F5-A2F8-9543ED54E089Q36999983-C7ADA85D-9A31-4FC9-B8FC-E5D08B4F49C6Q37024725-B2DA18DA-88AF-49E6-8BA7-CBABD0E4CA97Q37659886-2582E035-7F95-4C97-940D-6070A5CF6156Q38089865-F96CA34F-101E-4FF8-80DD-F36437BD8F27Q40773270-83501232-C127-4E71-BEF1-6D84DA5E07D6Q40987116-2A7BC88C-52B6-47CA-B068-24C8BA1CCE24Q41930742-81C4EF74-9F9C-4663-BB65-40401FB48ED4Q42212423-3A57A7A2-68FF-45EB-B441-40DCCBBA1716Q43076601-47B9B404-283B-4CD7-8DA7-234AA82746D4Q46907418-A65C0218-0331-4915-AD84-3B99292C156BQ47265464-E9FECED5-8241-47D3-9793-71466C69B80FQ57976568-911D85A7-DDE9-4EA4-AD7F-27E3A509D9D2
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
RNA aptamers as pathway-specific MAP kinase inhibitors.
@ast
RNA aptamers as pathway-specific MAP kinase inhibitors.
@en
type
label
RNA aptamers as pathway-specific MAP kinase inhibitors.
@ast
RNA aptamers as pathway-specific MAP kinase inhibitors.
@en
prefLabel
RNA aptamers as pathway-specific MAP kinase inhibitors.
@ast
RNA aptamers as pathway-specific MAP kinase inhibitors.
@en
P2093
P1476
RNA aptamers as pathway-specific MAP kinase inhibitors.
@en
P2093
Seiwert SD
Stines Nahreini T
Uhlenbeck OC
P304
P356
10.1016/S1074-5521(00)00032-6
P577
2000-11-01T00:00:00Z